HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Miyoshi Selected Research

Cystatin C

9/2018Corrigendum to "Serum cystatin C levels are associated with coronary artery calcification in women without chronic kidney disease" [J. Cardiol. 70 (2017) 559-564].
12/2017Serum cystatin C levels are associated with coronary artery calcification in women without chronic kidney disease.
7/2013Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Miyoshi Research Topics

Disease

20Heart Failure
09/2023 - 03/2011
18Myocardial Infarction
01/2023 - 10/2004
17Coronary Artery Disease (Coronary Atherosclerosis)
09/2023 - 03/2010
15Atherosclerosis
01/2022 - 07/2006
12Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 03/2011
11Inflammation (Inflammations)
04/2023 - 01/2008
9Atrial Fibrillation
04/2023 - 07/2009
8Acute Coronary Syndrome
05/2024 - 01/2014
8Pathologic Constriction (Stenosis)
04/2023 - 09/2008
8Hypertension (High Blood Pressure)
11/2021 - 01/2010
8Stable Angina
02/2021 - 03/2010
7Ischemia
01/2024 - 10/2005
7Spasm (Spasms)
03/2016 - 01/2014
6Insulin Resistance
03/2022 - 07/2010
6Hypertriglyceridemia
01/2022 - 08/2011
6Hypertrophy
05/2019 - 12/2010
6Infarction (Infarctions)
01/2016 - 10/2004
5Neoplasms (Cancer)
01/2023 - 10/2004
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 07/2014
5Fibrosis (Cirrhosis)
01/2021 - 12/2010
5Body Weight (Weight, Body)
05/2019 - 11/2008
4Hypoxia (Hypoxemia)
07/2023 - 06/2009
4Pulmonary Arterial Hypertension
07/2023 - 04/2017
4Diabetes Mellitus
05/2022 - 06/2018
4Chest Pain (Chest Pains)
02/2022 - 02/2016
4Death (Near-Death Experience)
01/2022 - 03/2011
4Hypercholesterolemia
01/2022 - 06/2015
4Thrombosis (Thrombus)
06/2019 - 05/2016
4Chronic Renal Insufficiency
01/2019 - 12/2017
4Hyperlipidemias (Hyperlipidemia)
04/2016 - 08/2011
3Non-alcoholic Fatty Liver Disease
05/2024 - 01/2021
3Myocarditis (Carditis)
10/2023 - 01/2021
3Ventricular Fibrillation
10/2023 - 01/2014
3Rupture
05/2023 - 05/2017
3Stroke (Strokes)
01/2023 - 01/2021
3ST Elevation Myocardial Infarction
10/2022 - 01/2015
3Coronary Disease (Coronary Heart Disease)
09/2022 - 08/2011
3Acute Kidney Injury (Acute Renal Failure)
02/2021 - 01/2015
3Unstable Angina
09/2019 - 01/2014
3Cardiomegaly (Heart Hypertrophy)
05/2019 - 02/2014
3Atherosclerotic Plaque (Atheroma)
03/2014 - 03/2010
2Cardiac Arrhythmias (Arrythmia)
10/2023 - 02/2017
2Shock
09/2023 - 01/2016
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
06/2023 - 01/2016
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
05/2023 - 01/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 04/2014

Drug/Important Bio-Agent (IBA)

13Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 08/2011
9LipidsIBA
01/2024 - 08/2011
9Phenobarbital (Luminal)FDA Link
12/2022 - 01/2015
8oxidized low density lipoproteinIBA
08/2023 - 11/2006
8LDL CholesterolIBA
08/2023 - 07/2011
8Eicosapentaenoic AcidIBA
06/2018 - 03/2011
6omega-Chloroacetophenone (Mace)IBA
05/2024 - 03/2011
6Messenger RNA (mRNA)IBA
07/2023 - 10/2004
6Biomarkers (Surrogate Marker)IBA
04/2023 - 07/2013
6voglibose (Basen)IBA
01/2022 - 07/2014
6Fatty Acid-Binding ProteinsIBA
10/2017 - 07/2010
6Acetylcholine (Acetylcholine Chloride)FDA Link
03/2016 - 01/2015
5Sodium-Glucose Transport ProteinsIBA
03/2022 - 01/2019
5C-Reactive ProteinIBA
01/2022 - 01/2005
5Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 07/2009
5Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017 - 11/2008
5olmesartanIBA
03/2014 - 03/2010
4pitavastatin (itavastatin)FDA Link
08/2023 - 01/2018
4Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2008
4Triglycerides (Triacylglycerol)IBA
09/2022 - 07/2011
41,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
01/2022 - 01/2019
4Glycoside Hydrolase InhibitorsIBA
01/2022 - 07/2014
4Nicorandil (SG 75)IBA
02/2021 - 06/2017
4LDL Lipoproteins (beta Lipoproteins)IBA
01/2020 - 10/2014
4Angiotensin Receptor AntagonistsIBA
03/2019 - 03/2014
4Ezetimibe (Zetia)FDA Link
06/2015 - 08/2011
4Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2008 - 11/2006
3AlbuminsIBA
09/2023 - 01/2010
3EnzymesIBA
05/2023 - 10/2004
3CalciumIBA
04/2023 - 01/2021
3Malondialdehyde (Propanedial)IBA
05/2022 - 09/2019
3Sodium-Glucose Transporter 2 InhibitorsIBA
03/2022 - 01/2019
3Lipoproteins (Lipoprotein)IBA
01/2022 - 04/2014
3Bisoprolol (Concor)FDA LinkGeneric
11/2021 - 08/2011
3MonocrotalineIBA
01/2021 - 04/2017
3Cystatin CIBA
09/2018 - 07/2013
3Ergonovine (Ergometrine)IBA
03/2016 - 09/2015
3Apolipoproteins E (ApoE)IBA
05/2009 - 01/2008
3ApolipoproteinsIBA
05/2009 - 07/2006
2Adenosine Triphosphate (ATP)IBA
10/2023 - 07/2023
2Alanine Transaminase (SGPT)IBA
09/2023 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2023 - 01/2021
2TolvaptanFDA Link
04/2023 - 02/2016
2Lipoprotein(a)IBA
05/2022 - 06/2018
2evolocumabIBA
05/2022 - 12/2020
2Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2022
2PPAR alphaIBA
01/2022 - 01/2022
2DiureticsIBA
01/2022 - 01/2017

Therapy/Procedure

23Therapeutics
01/2024 - 06/2005
23Percutaneous Coronary Intervention
09/2023 - 03/2009
5Catheter Ablation
04/2023 - 09/2008
5Stents
01/2019 - 05/2016
2Thrombectomy
10/2023 - 06/2019
2Drug Therapy (Chemotherapy)
05/2023 - 01/2022